Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Torin 2
Cat. No.:
OB0225LY-0372
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Torin 2 is a potent mTOR inhibitor that regulates cell growth and metabolism.
Synonym:
1223001-51-1; TorIN2; Torin-2; 9-(6-Aminopyridin-3-yl)-1-[3-(trifluoromethyl)phenyl]benzo[H][1,6]naphthyridin-2-one; 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)-phenyl)benzo[H][1,6]naphthyridin-2(1H)-one
CAS No.:
1223001-51-1
Compound CID:
51358113
Formula:
C24H15F3N4O
Formula Weight:
432.4
Specification
Relative Density:
1.427 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Torin 2 can be used to study metabolic diseases.
Library Information
Targets:
Kinases
Receptors:
ATM; ATR; DNA-PK; mTOR
Pathways:
Apoptosis; DNA damage/DNA repair; Autophagy; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-5
Plate Location:
g7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
1 mg/ml
ALogP:
4.323
HBA_Count:
3
HBD_Count:
1
Rotatable Bond:
3
